Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Osteolysis

idarubicin has been researched along with Osteolysis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavenagh, J; Ingram, W; Quinn, J; Smith, D; Stevens, J; Yong, K1
López Carrizosa, MC; Ortiz Cruz, E; Rodríguez Pérez, A; Samper Ots, PM; Villalón Blanco, L1
Dunkley, S; Gibson, J; Iland, H; Joshua, D; Li, C1

Other Studies

3 other study(ies) available for idarubicin and Osteolysis

ArticleYear
Myeloma presenting during pregnancy.
    Hematological oncology, 2014, Volume: 32, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cesarean Section; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Contraindications; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypercalcemia; Idarubicin; Infant, Newborn; Lenalidomide; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Myeloma Proteins; Osteolysis; Plasmacytoma; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrazines; Remission Induction; Spinal Cord Compression; Thalidomide; Thoracic Vertebrae; Transplantation, Autologous

2014
Granulocytic sarcoma of the right humerus in a non-leukaemia patient.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:11

    Topics: Aged; Antineoplastic Agents; Arthroplasty, Replacement; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Female; Fractures, Spontaneous; Humans; Humerus; Idarubicin; Osteolysis; Remission Induction; Sarcoma, Myeloid; Shoulder Fractures

2008
Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Lineage; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Combined Modality Therapy; Diphosphonates; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Idarubicin; Immunoglobulin kappa-Chains; Leukemia, Promyelocytic, Acute; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Proteins; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Osteolysis; Pamidronate; Prednisone; Remission Induction; Translocation, Genetic; Tretinoin

1999